logo

For the Inventor, By the Inventor

Narashino, Japan

Kazunori Maebashi

This inventor holds 14 USPTO granted patents. Top assignees: Ssp Co. Ltd, Ss Pharmaceutical Co., Ltd.. Active years: 1992-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunori Maebashi. Retrieved from https://idiyas.com/inventor/kazunori-maebashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 100.0

Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal8 out of 27 
 
Ssp Co. Ltd
 patents
silverMedal6 out of 90 
 
Ss Pharmaceutical Co., Ltd.
 patents

Years Active: 1992-2003

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6528500 - Azole derivatives or salts thereof (2003-03-04),
2. 6204415 - Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (2001-03-20),
3. 6194592 - Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (2001-02-27),
4. 6184396 - Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (2001-02-06),
5. 6172266 - Triazole derivative or slat thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (2001-01-09),
6. 6083968 - Triazole derivative or salt thereof, preparation process thereof and (2000-07-04),
7. 6063945 - Triazole derivative or salt thereof (2000-05-16),
8. 6040325 - Triazole derivative or salt thereof preparation process thereof, and (2000-03-21),
9. 6008239 - Triazole derivative or salt thereof (1999-12-28),
10. 6002028 - Triazole derivative, preparation process thereof and pharmaceutical (1999-12-14),
11. 5986144 - Triazole derivative, preparation process thereof and pharmaceutical (1999-11-16),
12. 5945438 - Triazole derivative and pharmaceutical comprising the same as an (1999-08-31),
13. 5939448 - Triazole derivative or salt thereof (1999-08-17),
14. 5147886 - Triazole derivatives and a composition for treating mycoses (1992-09-15),

Title: Kazunori Maebashi: A Notable Inventor in Pharmaceutical Innovations

Introduction

Kazunori Maebashi, based in Narashino, Japan, is a distinguished inventor with a remarkable portfolio of 14 patents. His contributions primarily focus on pharmaceutical innovations, showcasing his expertise in developing new compounds with potential therapeutic applications.

Latest Patents

Among his latest patents, Maebashi has developed azole derivatives and triazole derivatives, including their salts. These inventions involve a specific preparation process, where he describes a triazole derivative represented by a defined formula. These compounds are positioned as effective ingredients within pharmaceutical formulations, highlighting their relevance in medical advancements.

Career Highlights

Throughout his career, Kazunori Maebashi has been associated with respected companies, including Ssp Co. Ltd and Ss Pharmaceutical Co., Ltd. His work in these organizations has played a significant role in advancing research and development in the pharmaceutical field.

Collaborations

Maebashi has also collaborated with esteemed colleagues, including Minoru Tokizawa and Masaru Matsumoto. These collaborations have contributed to his successful patent filings and the overall progress in innovative pharmaceutical solutions.

Conclusion

In summary, Kazunori Maebashi is a prominent figure in the realm of pharmaceutical innovations. His extensive patent portfolio and collaborations underscore his commitment to enhancing healthcare through scientific advancements. His work continues to inspire future inventions that can positively impact society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…